A whole genome scale proteome array consisting of 908 open reading frames encoded in
Chlamydia trachomatis genome and plasmid was used to profile anti-chlamydial Ab …

A comprehensive proteomic screening technology was previously used to characterize T
cell responses to Chlamydia trachomatis infection. In this study, we demonstrated that T cells …

The obligate intracellular bacterium Chlamydia trachomatis is the causative agent of
sexually transmitted chlamydia infections. A panel of 116 recombinant C. trachomatis …

Chlamydia trachomatis is the most common bacterial sexually transmitted pathogen in the
world. In order to control this infection there is an urgent need to formulate a vaccine …

Chlamydia trachomatis infections can lead to severe chronic complications, including
trachoma, ectopic pregnancy, and infertility. The only effective approach to disease control is …

The available chlamydial genome sequences have made it possible to comprehensively
analyze host responses to all chlamydial proteins, which is essential for further …

Chlamydia trachomatis infection is the most common sexually transmitted bacterial infection
worldwide, with over 91 million cases estimated annually. An effective subunit vaccine …

Vaccine development for Chlamydia species has progressed on several research fronts,
including knowledge of the components of the immune response required for immunity and …

The immune correlates of protection for most of the currently used vaccines are based on
long-lived humoral immunity. Vaccines based on humoral immunity alone are unlikely to …

Chlamydia trachomatis is the most common cause of sexually transmitted bacterial infection
globally. These infections translate to a significant public health burden, particularly …